Evidence map›Paper›PMID 22226839›Full record

ArticleJournal of molecular biology2012

Crystal structure and regulation mechanisms of the CyaB adenylyl cyclase from the human pathogen Pseudomonas aeruginosa.

Hüsnü Topal, Nanette B Fulcher, Jacob Bitterman, Eric Salazar, Jochen Buck, Lonny R Levin, Martin J Cann, Matthew C Wolfgang, Clemens Steegborn

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 44 citations in OpenAlex.

  1. Distinct roles of PilI and ChpC inApplied and environmental microbiology · 2026
    Article
  2. Control of cell division by anbioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Unraveling the molecular dynamics ofFuture microbiology · 2024
    Article
  8. Review
  9. How Bacterial Pathogens Coordinate Appetite with Virulence.Microbiology and molecular biology reviews : MMBR · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Pharmacological modulation of the COPharmacology & therapeutics · 2018
    Review
  16. Role of the nucleotidyl cyclase helical domain in catalytically active dimer formation.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Hüsnü TopalDepartment of Physiological Chemistry, Ruhr-University Bochum, 44801 Bochum, Germany.
Nanette B Fulcher
Jacob Bitterman
Eric Salazar
Jochen Buck
Lonny R Levin
Martin J Cann
Matthew C Wolfgang
Clemens Steegborn
Cornell University · USUniversity of North Carolina at Chapel Hill · USDurham University · GBRuhr University Bochum · DEUniversity of Bayreuth · DE

Funding

Predoctoral Training in Pharmacological SciencesT32GM073546 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI GROSS, STEVEN S · 2006 to 2020
$3.1M
New target for malaria drug developmentR01AI064842 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI LEVIN, LONNY R · 2005 to 2008
$1.4M
Cyclic AMP Signaling in Pseudomonas aeruginosa VirulenceR01AI069116 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WOLFGANG, MATTHEW C · 2008 to 2011
$1.3M
NIAID NIH HHS AI069116NIAID NIH HHS R01 AI064842NIAID NIH HHS R01 AI069116NIGMS NIH HHS T32 GM073546Wellcome Trust
6 · The paper itself

Abstract

Pseudomonas aeruginosa is an opportunistic bacterial pathogen and a major cause of healthcare-associated infections. While the organism's intrinsic and acquired resistance to most antibiotics hinders treatment of P. aeruginosa infections, the regulatory networks controlling its virulence provide novel targets for drug development. CyaB, a key regulator of P. aeruginosa virulence, belongs to the Class III adenylyl cyclase (AC) family of enzymes that synthesize the second messenger cyclic adenosine 3',5'-monophosphate. These enzymes consist of a conserved catalytic domain fused to one or more regulatory domains. We describe here the biochemical and structural characterization of CyaB and its inhibition by small molecules. We show that CyaB belongs to the Class IIIb subfamily, and like other subfamily members, its activity is stimulated by inorganic carbon. CyaB is also regulated by its N-terminal MASE2 (membrane-associated sensor 2) domain, which acts as a membrane anchor. Using a genetic screen, we identified activating mutations in CyaB. By solving the crystal structure of the CyaB catalytic domain, we rationalized the effects of these mutations and propose that CyaB employs regulatory mechanisms similar to other Class III ACs. The CyaB structure further indicates subtle differences compared to other Class III ACs in both the active site and the inhibitor binding pocket. Consistent with these differences, we observed a unique inhibition profile, including identification of a CyaB selective compound. Overall, our results reveal mechanistic details of the physiological and pharmacological regulation of CyaB and provide the basis for its exploitation as a therapeutic drug target.

Indexed as

Adenylyl CyclasesBacterial ProteinsCrystallography, X-RayCyclic AMPHumansPseudomonas aeruginosaAdenylyl CyclasesBacterial ProteinsCyclic AMP

Identifiers

PMID22226839
PMCPMC3269522
OpenAlexW2069017792

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.